IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 167 filers reported holding IMMUNOMEDICS INC in Q4 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $18,821,000 | +15.5% | 221,351 | -51.9% | 1.67% | -5.0% |
Q2 2020 | $16,302,000 | +105.0% | 460,000 | -22.0% | 1.76% | +58.1% |
Q1 2020 | $7,953,000 | -46.3% | 590,000 | -15.7% | 1.11% | -31.4% |
Q4 2019 | $14,812,000 | +31.4% | 700,000 | -17.6% | 1.62% | +14.9% |
Q3 2019 | $11,271,000 | -4.5% | 850,000 | -0.2% | 1.41% | +8.6% |
Q2 2019 | $11,808,000 | -0.3% | 851,367 | +38.1% | 1.30% | -6.1% |
Q1 2019 | $11,840,000 | +72.7% | 616,367 | +28.3% | 1.38% | +76.9% |
Q4 2018 | $6,854,000 | -22.6% | 480,330 | +12.9% | 0.78% | -11.8% |
Q3 2018 | $8,860,000 | -17.8% | 425,330 | -6.6% | 0.89% | -19.5% |
Q2 2018 | $10,778,000 | +77.6% | 455,330 | +9.6% | 1.10% | +47.5% |
Q1 2018 | $6,068,000 | -21.8% | 415,330 | -13.5% | 0.75% | -28.7% |
Q4 2017 | $7,762,000 | +11.0% | 480,330 | -3.9% | 1.05% | +17.6% |
Q3 2017 | $6,990,000 | +49.5% | 500,000 | -5.6% | 0.89% | +32.9% |
Q2 2017 | $4,676,000 | +50.7% | 529,610 | +10.4% | 0.67% | +36.7% |
Q1 2017 | $3,103,000 | – | 479,610 | – | 0.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,711,067 | $2,943,000 | 1.70% |
J.P. Turner & Co Capital Mnagement, LLC | 248,625 | $428,000 | 0.44% |
Orbimed Advisors | 3,323,000 | $5,716,000 | 0.06% |
BALYASNY ASSET MANAGEMENT L.P. | 2,004,078 | $3,447,000 | 0.02% |
WOLVERINE ASSET MANAGEMENT LLC | 5,870 | $1,018,000 | 0.02% |
SIGNET FINANCIAL MANAGEMENT, LLC | 44,675 | $77,000 | 0.02% |
SVB WEALTH LLC | 195,000 | $335,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 288,900 | $497,000 | 0.01% |
J.P. Turner & Co Capital Mnagement, LLC | 153,900 | $8,000 | 0.01% |
BALYASNY ASSET MANAGEMENT L.P. | 640,400 | $1,101,000 | 0.01% |